Health literacy: the hidden key to safer clinical research and better medical device use

Picture of Maurice Bagot D'arc

Maurice Bagot D'arc

ENT surgeon, head and neck surgeon, specialized in ENT oncology, legal compensation for bodily injury, and pharmaceutical marketing, with over 30 years of experience in Medical Affairs serving the healthcare industries and 15 years of surgical practice.

Health literacy is often mentioned but rarely mastered — and even less often integrated in a practical way into clinical evaluations or medical device (MD) usage.

Yet, the World Health Organization (WHO) report “Health Literacy: The Solid Facts” makes it clear: health literacy is not a theoretical concept but a major determinant of health, influencing understanding, behavior, prevention, safety, and patient autonomy.

How the WHO defines health literacy

The WHO defines health literacy as the ability to access, understand, evaluate, and use health-related information.
It encompasses a complex set of social, cognitive, and practical skills applicable to care, prevention, and health promotion.

According to the WHO report, 12 fundamental skills are grouped into three main areas:

  • Accessing information,
  • Understanding and interpreting information,
  • Making informed decisions.

Low health literacy has a direct impact on health outcomes

The WHO’s section “What is known” shows that limited health literacy has profound consequences. It is associated with:

  • Lower participation in prevention programs,
  • Riskier health behaviors,
  • Difficulty managing chronic diseases,
  • Poor treatment adherence,
  • More frequent hospitalizations,
  • Higher complication rates,
  • Increased mortality.

The WHO further notes that health literacy may be a better predictor of health status than income, education, or employment.

A major equity issue: literacy follows a social gradient

The report shows that limited literacy disproportionately affects:

  • Elderly individuals,
  • People with low educational attainment,
  • Migrants,
  • Economically vulnerable populations.

These groups often combine lower capacity to understand medical information with higher exposure to health risks.
In contrast, people with high health literacy tend to report better self-perceived health.

Health literacy varies by context and vulnerability

The WHO emphasizes a critical point: no one is fully health literate in every situation.
Even highly educated people may struggle depending on:

  • The complexity of the healthcare system,
  • Emotional stress or anxiety,
  • The level of cognitive load,
  • The type or stage of illness.

In summary, health literacy is situational, not static.

The economic impact of low health literacy

The WHO report documents the significant financial burden of low health literacy, particularly in Canada and the United States.
These additional costs stem from:

  • Preventable hospital admissions,
  • Medication errors,
  • Repeated consultations,
  • Misunderstanding of care instructions.

Creating “health literacy–friendly” environments can therefore reduce costs while improving safety and outcomes

What the WHO recommends: organizational actions, not just education

The WHO does not limit its recommendations to patient education.
It calls for systemic change to make organizations and healthcare systems more accessible and inclusive.

Key recommendations:

  • Develop health literacy–friendly environments,
  • Simplify communication and written materials,
  • Use visual aids and plain language,
  • Test comprehension of patient-facing documents,
  • Reduce administrative and cognitive complexity.

The report also highlights evidence that better health literacy improves:

  • Medication adherence,
  • Chronic disease management,
  • Patient safety and autonomy.

Clinical research: health literacy as a critical success factor

When health literacy is low, the risks multiply:

Clinical trials typically involve long, technical documents with complex concepts — consent forms, protocols, procedures, self-assessments, and withdrawal instructions.

  • Misunderstanding of informed consent,
  • Errors in self-reported measures,
  • Missing data or incomplete follow-up,
  • Underreporting of adverse events,
  • Increased stress and early withdrawal from the study.

For medical devices, particularly those used directly by patients, health literacy becomes a core determinant of clinical performance and safety.

It affects the ability to:

  • Understand instructions for use,
  • Follow procedural steps correctly,
  • Respond appropriately to alerts,
  • Install or configure a device,
  • Use a connected application,
  • Interpret numerical results.

Even a simple medical device requires a minimum comprehension level, which varies widely among patient profiles.

The need for targeted patient selection and adaptive support

In clinical trials involving medical devices, selecting “all eligible patients” is not always appropriate.
Some may be clinically eligible but unable to operate the device or follow complex procedures.

This is not a patient limitation — it’s a design limitation.

Integrating health literacy assessment into clinical trials allows sponsors to:

  • Better target participants,
  • Adapt materials and explanations,
  • Reduce misuse and data errors,
  • Improve clinical validity,
  • Strengthen patient safety,
  • Increase data robustness.

For manufacturers, this means devices must be designed and tested according to the actual literacy levels of end-users, not idealized ones.

Conclusion: health literacy — a measurable and powerful determinant

As defined by the World Health Organization, health literacy is not an abstract idea.
It is a measurable determinant that directly influences:

  • Understanding,
  • Safety,
  • Adherence,
  • Data quality, and
  • Clinical outcomes.

In clinical research and medical devices, health literacy is essential: without adequate understanding, neither documents, devices, nor protocols can deliver the expected results.

The challenge for today’s clinical research and medtech industries is no longer purely technological or regulatory — it is also cognitive, educational, and human.

Useful links

Other articles to consult

Participez au webinaire

Présentation de BluePharm Academy : Les modules de formation de BluePharm